GLP-1 Agonists have shown benefits in diabetes management, but do those translate to better #PAD outcomes? Here is the next article in our #Simulpub series. https://t.co/7aGjc61VLz
Excellent presentation and poster by @christinalcui on development and implementation of an SSI bundle for lower extremity bypass at #VAM25#VQI@DukeSurgery
Vascular micro- and macro- calcification from 18F-NaF PET/CT can be mapped onto a spatial
atlas, serving as a novel technique to sensitively detect and track vascular calcification across
space a... @A_sheppard9@babaksaboury@Faraz_Farhadi@elizabeththeng
https://t.co/S0Og0imJwA
Proud to share our hard work @camila_both@InstituteStarzl published this week in @ScienceTM harnessing the potential of regulatory immunotherapy in an early clinical trial
A team led by @lmtranmd finds that infusions of regulatory #DendriticCells from liver transplant donors can “teach��� recipients’ T cells to tolerate grafts, and could potentially reduce patient reliance on standard immunosuppressive drugs. @InstituteStarzl https://t.co/F0zoW91FPG
“Despite surgical diseases making up 30% of the global disease burden, representation of surgeon-scientists among NIH investigators remains less than 2%.”
Great study- let’s close the gap!
Swarming, self-adhesive microgels can block and successfully prevent bleeding from an aneurysm. Researchers in @ScienceAdvances created an interventional catherization platform to deliver microgels to aneurysm sites for treatment. https://t.co/n65pQnIzos
Amazing work from surg resident Shimena Li on TXA benefit from the STAAMP trial @pitttrauma @PittTraumaRes @Guyettef @joshua_b_brown https://t.co/gYg8bhLccM